GW Pharma (GWPH) Posts Q3 Loss of 6c/Share; THCV Phase 2 Missed Primary Endpoint in T2D

Go back to GW Pharma (GWPH) Posts Q3 Loss of 6c/Share; THCV Phase 2 Missed Primary Endpoint in T2D
GW PHARM SP ADS (NASDAQ: GWPH) Delayed: 218.96 --0 (-0%)
Previous Close $218.96    52 Week High $137.88 
Open $1.76    52 Week Low $35.83 
Day High $218.96    P/E N/A 
Day Low $218.96    EPS $0.00 
Volume 172,734